14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.05 $2.79 Tuesday, 23rd Apr 2024 FGEN stock ended at $1.07. This is 6.14% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 20.00% from a day low at $1.05 to a day high of $1.26.
90 days $0.85 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Jul 12, 2021 $26.72 $26.95 $25.24 $25.39 1 265 762
Jul 09, 2021 $26.41 $26.98 $25.95 $26.47 557 679
Jul 08, 2021 $24.62 $26.53 $24.41 $26.41 638 253
Jul 07, 2021 $25.24 $25.67 $24.70 $25.05 392 001
Jul 06, 2021 $26.98 $27.10 $24.61 $25.06 854 281
Jul 02, 2021 $26.58 $26.84 $26.05 $26.64 577 207
Jul 01, 2021 $26.77 $26.82 $25.55 $26.50 743 119
Jun 30, 2021 $26.89 $27.18 $26.49 $26.63 642 542
Jun 29, 2021 $27.59 $27.88 $26.85 $27.01 598 292
Jun 28, 2021 $27.89 $28.45 $26.99 $27.64 616 858
Jun 25, 2021 $29.89 $30.12 $26.44 $27.67 2 156 162
Jun 24, 2021 $29.00 $29.45 $28.80 $29.09 940 668
Jun 23, 2021 $27.73 $28.88 $27.55 $28.80 1 123 038
Jun 22, 2021 $27.60 $28.04 $27.19 $27.65 717 602
Jun 21, 2021 $27.12 $28.04 $26.14 $27.82 1 337 766
Jun 18, 2021 $25.82 $26.99 $25.82 $26.96 1 402 291
Jun 17, 2021 $25.70 $26.50 $25.70 $26.29 423 784
Jun 16, 2021 $25.30 $25.92 $25.00 $25.84 732 896
Jun 15, 2021 $25.62 $25.82 $24.64 $25.38 706 656
Jun 14, 2021 $26.03 $26.51 $25.43 $25.82 844 362
Jun 11, 2021 $25.32 $26.09 $25.00 $26.06 668 897
Jun 10, 2021 $24.62 $25.23 $24.18 $25.15 594 314
Jun 09, 2021 $24.37 $25.18 $24.25 $24.56 1 069 167
Jun 08, 2021 $22.96 $24.47 $22.17 $24.25 1 463 645
Jun 07, 2021 $21.39 $23.15 $21.20 $22.90 1 407 429
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT